As of 2026-10-09, the Relative Valuation of Cara Therapeutics Inc (CARA) is (175.23) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.32 USD, the upside of Cara Therapeutics Inc based on Relative Valuation is -3393.8%.
The range of the Relative Valuation is (126.23) - (190.12) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.9x - 12.3x | 11.4x |
| Forward P/E multiples | 8.1x - 12.6x | 11.2x |
| Fair Price | (126.23) - (190.12) | (175.23) |
| Upside | -2472.7% - -3673.6% | -3393.8% |
| Date | P/E |